European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 115-118, December 2008

Familial Mediterranean fever during pregnancy: An independent risk factor for preterm delivery

  • Danielle Ofir

      Affiliations

    • Departments of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben Gurion University of the Negev, Be’er-Sheva, Israel
  • ,
  • Amalia Levy

      Affiliations

    • Epidemiology and Health Services Evaluation, Faculty of Health Sciences, Ben Gurion University of the Negev, Be’er-Sheva, Israel
  • ,
  • Arnon Wiznitzer

      Affiliations

    • Departments of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben Gurion University of the Negev, Be’er-Sheva, Israel
  • ,
  • Moshe Mazor

      Affiliations

    • Departments of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben Gurion University of the Negev, Be’er-Sheva, Israel
  • ,
  • Eyal Sheiner

      Affiliations

    • Departments of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben Gurion University of the Negev, Be’er-Sheva, Israel
    • Corresponding Author InformationCorresponding author at: Department of Obstetrics and Gynecology, Soroka University Medical Center, P.O. Box 151, Be’er-Sheva, Israel. Tel.: +972 8 6400774; fax: +972 8 6275338.

Received 6 May 2008; received in revised form 13 July 2008; accepted 22 July 2008. published online 26 August 2008.

Abstract 

Objective

To investigate pregnancy outcome of patients with Familial Mediterranean fever (FMF).

Study design

A population-based study comparing all pregnancies of women with and without FMF between the years 1988 and 2006 was conducted. Stratified analyses, using the Mantel–Haenszel procedure and multiple logistic regression models, were performed to control for confounders.

Results

During the study period there were 175,572 deliveries, of which 239 occurred in patients with FMF. Using a multivariable analysis, the following conditions were significantly associated with FMF: preterm delivery (PTD, <37 weeks) (odds ratio (OR)=1.5; 95% confidence interval (CI) 1.1–2.2), fertility treatments (OR=2.5; 95% CI 1.4–4.4), recurrent abortions (OR=2.2; 95% CI 1.5–3.2), labor induction (OR=1.9; 95% CI 1.5–2.5) and malpresentations (OR=1.8; 95% CI 1.2–2.8). Patients with FMF were more likely to deliver by cesarean delivery (CD) as compared to the comparison group (18.0% vs. 12.8%; P=0.017). However, while controlling for possible confounders such as malpresentations, labor dystocia and failed induction, using multivariable analysis with CD as the outcome variable, FMF was not found as an independent risk factor for CD (adjusted OR=1.2; 95% CI 0.8–1.8, P=0.388). No significant differences were noted between the groups regarding perinatal outcomes such as low Apgar scores (<7) at 1 and 5min (2.4% vs. 4.3%, P=0.153 and 0.4% vs. 0.6%, P=0.692; respectively), congenital malformations (5.2% vs. 4.9%, P=0.838), or perinatal mortality (0.8% vs. 1.4%, P=0.445). Stratified analysis, using the Mantel–Haenszel technique, was used to assess the association between FMF and PTD while controlling for possible confounders such as iatrogenic labor induction, fertility treatments, recurrent abortions and placental abruption. None of those variables explained the higher incidence of PTD in the group of patients with FMF.

Conclusion

Familial Mediterranean fever is an independent risk factor for preterm delivery. Nevertheless, perinatal outcome is comparable to the general population.

Keywords: FMF, Preterm delivery, Cesarean delivery, Pregnancy outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented in part at the 28th Annual Meeting of the Society of Maternal Fetal Medicine (SMFM), Dallas, TX, CA, USA, January 28–February 2, 2008.

PII: S0301-2115(08)00302-3

doi:10.1016/j.ejogrb.2008.07.025

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 115-118, December 2008